Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Nanosonics Limited ( (AU:NAN) ) has shared an update.
Nanosonics Limited has provided an update on its ongoing on-market share buy-back program for its ordinary fully paid shares. The company reported that, as of the latest notification dated 12 March 2026, it had repurchased a cumulative total of 2,406,628 shares before the previous trading day and an additional 200,000 shares on the previous day.
The filing reflects a routine daily disclosure in line with ASX requirements and indicates the continued execution of the buy-back first notified in December 2025. This sustained activity underscores Nanosonics’ current capital management strategy, which may support earnings per share and signal confidence in the company’s valuation to existing and prospective investors.
The most recent analyst rating on (AU:NAN) stock is a Buy with a A$5.55 price target. To see the full list of analyst forecasts on Nanosonics Limited stock, see the AU:NAN Stock Forecast page.
More about Nanosonics Limited
Nanosonics Limited is an Australian-listed medical technology company trading under the ASX code NAN. It issues ordinary fully paid shares and operates in the healthcare sector, where capital management, including on-market share buy-backs, forms part of its approach to optimising its balance sheet and shareholder returns.
Average Trading Volume: 542,515
Technical Sentiment Signal: Sell
Current Market Cap: A$1.12B
See more insights into NAN stock on TipRanks’ Stock Analysis page.